Main variables;Main activity, secondary one or a tool necessary for production;Total
Companies that carry out R&D in Biotechnology;Total;1.233
Companies that carry out R&D in Biotechnology;Main;615
Companies that carry out R&D in Biotechnology;Secondary dwellings;178
Companies that carry out R&D in Biotechnology;Tool;440
%Companies according to biotechnology used: Genetic code;Total;31,7
%Companies according to biotechnology used: Genetic code;Main;40,8
%Companies according to biotechnology used: Genetic code;Secondary dwellings;21,9
%Companies according to biotechnology used: Genetic code;Tool;22,8
%Companies according to biotechnology used: Functional units;Total;38,5
%Companies according to biotechnology used: Functional units;Main;45,5
%Companies according to biotechnology used: Functional units;Secondary dwellings;38,3
%Companies according to biotechnology used: Functional units;Tool;28,8
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total;22,8
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Main;28,2
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Secondary dwellings;21,2
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Tool;15,7
%Companies according to biotechnology used: Bioprocesses;Total;53,4
%Companies according to biotechnology used: Bioprocesses;Main;46,9
%Companies according to biotechnology used: Bioprocesses;Secondary dwellings;57,3
%Companies according to biotechnology used: Bioprocesses;Tool;60,8
%Companies according to biotechnology used: Sub-cellular organisms;Total;8,6
%Companies according to biotechnology used: Sub-cellular organisms;Main;12,5
%Companies according to biotechnology used: Sub-cellular organisms;Secondary dwellings;5,2
%Companies according to biotechnology used: Sub-cellular organisms;Tool;4,6
%Companies according to biotechnology used: Bio-computing;Total;22,3
%Companies according to biotechnology used: Bio-computing;Main;31,7
%Companies according to biotechnology used: Bio-computing;Secondary dwellings;15,1
%Companies according to biotechnology used: Bio-computing;Tool;12
%Companies according to biotechnology used: Nanobiotechnology;Total;10,6
%Companies according to biotechnology used: Nanobiotechnology;Main;13,9
%Companies according to biotechnology used: Nanobiotechnology;Secondary dwellings;15,2
%Companies according to biotechnology used: Nanobiotechnology;Tool;4,3
%Companies according to biotechnology used: Other;Total;14,2
%Companies according to biotechnology used: Other;Main;14,8
%Companies according to biotechnology used: Other;Secondary dwellings;17,1
%Companies according to biotechnology used: Other;Tool;12,2
%Company by field(s) of ultimate application of biotechnology use: Human Health;Total;46,3
%Company by field(s) of ultimate application of biotechnology use: Human Health;Main;63
%Company by field(s) of ultimate application of biotechnology use: Human Health;Secondary dwellings;37,1
%Company by field(s) of ultimate application of biotechnology use: Human Health;Tool;26,6
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total;16,2
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Main;19,7
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Secondary dwellings;16,9
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Tool;11,2
%Company by field(s) of ultimate application of biotechnology use: Food products;Total;32
%Company by field(s) of ultimate application of biotechnology use: Food products;Main;24,2
%Company by field(s) of ultimate application of biotechnology use: Food products;Secondary dwellings;29,9
%Company by field(s) of ultimate application of biotechnology use: Food products;Tool;43,9
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Total;24,6
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Main;22,5
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Secondary dwellings;30,1
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Tool;25,3
%Company by field(s) of ultimate application of biotechnology use: Environment;Total;15,5
%Company by field(s) of ultimate application of biotechnology use: Environment;Main;13,7
%Company by field(s) of ultimate application of biotechnology use: Environment;Secondary dwellings;26,8
%Company by field(s) of ultimate application of biotechnology use: Environment;Tool;13,4
%Company by field(s) of ultimate application of biotechnology use: Industry;Total;12,9
%Company by field(s) of ultimate application of biotechnology use: Industry;Main;14,3
%Company by field(s) of ultimate application of biotechnology use: Industry;Secondary dwellings;22,6
%Company by field(s) of ultimate application of biotechnology use: Industry;Tool;6,9
Personnel in R&D in biotechnology (no. of persons);Total;13.444
Personnel in R&D in biotechnology (no. of persons);Main;7.243
Personnel in R&D in biotechnology (no. of persons);Secondary dwellings;1.822
Personnel in R&D in biotechnology (no. of persons);Tool;4.379
Personnel in R&D in biotechnology (no. of persons): Researchers;Total;7.378
Personnel in R&D in biotechnology (no. of persons): Researchers;Main;4.139
Personnel in R&D in biotechnology (no. of persons): Researchers;Secondary dwellings;1.032
Personnel in R&D in biotechnology (no. of persons): Researchers;Tool;2.207
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total;6.066
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Main;3.105
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Secondary dwellings;790
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Tool;2.171
Personnel in R&D in biotechnology (no. of persons): women;Total;7.501
Personnel in R&D in biotechnology (no. of persons): women;Main;4.255
Personnel in R&D in biotechnology (no. of persons): women;Secondary dwellings;917
Personnel in R&D in biotechnology (no. of persons): women;Tool;2.329
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total;4.052
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Main;2.352
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Secondary dwellings;542
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Tool;1.158
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total;3.450
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Main;1.903
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Secondary dwellings;376
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Tool;1.171
Personnel in R&D in biotechnology (FTE);Total;9.401,9
Personnel in R&D in biotechnology (FTE);Main;5.696,8
Personnel in R&D in biotechnology (FTE);Secondary dwellings;1.025,3
Personnel in R&D in biotechnology (FTE);Tool;2.679,9
Personnel in R&D in biotechnology (FTE): Researchers;Total;5.398,3
Personnel in R&D in biotechnology (FTE): Researchers;Main;3.332,7
Personnel in R&D in biotechnology (FTE): Researchers;Secondary dwellings;675,7
Personnel in R&D in biotechnology (FTE): Researchers;Tool;1.389,9
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total;4.003,6
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Main;2.364,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Secondary dwellings;349,5
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Tool;1.290
Personnel in R&D in biotechnology (FTE): women;Total;5.426,2
Personnel in R&D in biotechnology (FTE): women;Main;3.428,5
Personnel in R&D in biotechnology (FTE): women;Secondary dwellings;556,8
Personnel in R&D in biotechnology (FTE): women;Tool;1.440,9
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total;3.016,4
Personnel in R&D in biotechnology (FTE): (women) Researchers;Main;1.924,6
Personnel in R&D in biotechnology (FTE): (women) Researchers;Secondary dwellings;360,1
Personnel in R&D in biotechnology (FTE): (women) Researchers;Tool;731,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total;2.409,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Main;1.503,9
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Secondary dwellings;196,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Tool;709,2
Internal expenditure on R&D (thousands of euros);Total;897.333
Internal expenditure on R&D (thousands of euros);Main;602.520
Internal expenditure on R&D (thousands of euros);Secondary dwellings;77.601
Internal expenditure on R&D (thousands of euros);Tool;217.211
1) By nature of the expense: Current expenses;Total;817.409
1) By nature of the expense: Current expenses;Main;541.269
1) By nature of the expense: Current expenses;Secondary dwellings;71.986
1) By nature of the expense: Current expenses;Tool;204.154
1.1) Remuneration to researchers;Total;295.705
1.1) Remuneration to researchers;Main;194.401
1.1) Remuneration to researchers;Secondary dwellings;32.922
1.1) Remuneration to researchers;Tool;68.382
1.2) Remuneration to technicians and assistants;Total;156.853
1.2) Remuneration to technicians and assistants;Main;98.937
1.2) Remuneration to technicians and assistants;Secondary dwellings;11.856
1.2) Remuneration to technicians and assistants;Tool;46.060
1.3) Other current expenses;Total;364.852
1.3) Other current expenses;Main;247.931
1.3) Other current expenses;Secondary dwellings;27.209
1.3) Other current expenses;Tool;89.712
2) By nature of the expense: Capital expenses;Total;79.924
2) By nature of the expense: Capital expenses;Main;61.251
2) By nature of the expense: Capital expenses;Secondary dwellings;5.615
2) By nature of the expense: Capital expenses;Tool;13.057
2.1) Land and buildings;Total;10.272
2.1) Land and buildings;Main;8.482
2.1) Land and buildings;Secondary dwellings;898
2.1) Land and buildings;Tool;892
2.2) Equipment and instruments;Total;56.609
2.2) Equipment and instruments;Main;41.244
2.2) Equipment and instruments;Secondary dwellings;4.323
2.2) Equipment and instruments;Tool;11.043
2.3) Acquisition of specific R+D software;Total;4.839
2.3) Acquisition of specific R+D software;Main;4.254
2.3) Acquisition of specific R+D software;Secondary dwellings;109
2.3) Acquisition of specific R+D software;Tool;476
2.4) Otros productos de propiedad intelectual específicos para I+D;Total;8.203
2.4) Otros productos de propiedad intelectual específicos para I+D;Main;7.271
2.4) Otros productos de propiedad intelectual específicos para I+D;Secondary dwellings;286
2.4) Otros productos de propiedad intelectual específicos para I+D;Tool;647
1.1) By origin of the funds: Own funds;Total;613.097
1.1) By origin of the funds: Own funds;Main;418.567
1.1) By origin of the funds: Own funds;Secondary dwellings;47.014
1.1) By origin of the funds: Own funds;Tool;147.516
1.2) By origin of the funds: From companies;Total;86.085
1.2) By origin of the funds: From companies;Main;44.282
1.2) By origin of the funds: From companies;Secondary dwellings;10.408
1.2) By origin of the funds: From companies;Tool;31.395
1.3) By origin of the funds: Public Administration funds;Total;92.140
1.3) By origin of the funds: Public Administration funds;Main;56.901
1.3) By origin of the funds: Public Administration funds;Secondary dwellings;11.393
1.3) By origin of the funds: Public Administration funds;Tool;23.846
1.4) By origin of the funds: From Universities;Total;853
1.4) By origin of the funds: From Universities;Main;519
1.4) By origin of the funds: From Universities;Secondary dwellings;0
1.4) By origin of the funds: From Universities;Tool;335
1.5) By origin of the funds: From non profit private institutions;Total;4.682
1.5) By origin of the funds: From non profit private institutions;Main;1.965
1.5) By origin of the funds: From non profit private institutions;Secondary dwellings;0
1.5) By origin of the funds: From non profit private institutions;Tool;2.717
1.6) By origin of the funds: Foreign funds;Total;100.476
1.6) By origin of the funds: Foreign funds;Main;80.287
1.6) By origin of the funds: Foreign funds;Secondary dwellings;8.786
1.6) By origin of the funds: Foreign funds;Tool;11.403
Purchase of R&D services in biotechnology (thousands of euros);Total;85.011
Purchase of R&D services in biotechnology (thousands of euros);Main;62.516
Purchase of R&D services in biotechnology (thousands of euros);Secondary dwellings;14.617
Purchase of R&D services in biotechnology (thousands of euros);Tool;7.878
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Total;54.243
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Main;36.965
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Secondary dwellings;11.023
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Tool;6.255
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Total;30.768
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Main;25.552
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Secondary dwellings;3.594
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Tool;1.622
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total;39,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Main;48,3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Secondary dwellings;36,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Tool;27,7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total;11,7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Main;10,9
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Secondary dwellings;15,3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Tool;11,4
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total;12,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Main;12,7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Secondary dwellings;12,8
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Tool;12,1
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total;10,9
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Main;12
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Secondary dwellings;9,4
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Tool;9,9
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Total;14
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Main;16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Secondary dwellings;14
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Tool;12
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Total;17
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Main;21
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Secondary dwellings;15
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Tool;11
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Total;15
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Main;16
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Secondary dwellings;15
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Tool;14
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total;36
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Main;42
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Secondary dwellings;35
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Tool;27
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Total;47
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Main;53
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Secondary dwellings;44
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Tool;39
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total;19
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Main;21,8
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Secondary dwellings;17,6
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Tool;15,6
% Companies that have requested biotechnology patents;Total;17
% Companies that have requested biotechnology patents;Main;25
% Companies that have requested biotechnology patents;Secondary dwellings;16
% Companies that have requested biotechnology patents;Tool;7
Number of patents requested;Total;681
Number of patents requested;Main;473
Number of patents requested;Secondary dwellings;65
Number of patents requested;Tool;144
% Companies with income of an international origin related to biotechnological activities;Total;23
% Companies with income of an international origin related to biotechnological activities;Main;28,9
% Companies with income of an international origin related to biotechnological activities;Secondary dwellings;17,9
% Companies with income of an international origin related to biotechnological activities;Tool;17
% Turnover representing income of an international origin related to biotechnological activities;Total;1,6
% Turnover representing income of an international origin related to biotechnological activities;Main;9,4
% Turnover representing income of an international origin related to biotechnological activities;Secondary dwellings;0,1
% Turnover representing income of an international origin related to biotechnological activities;Tool;0,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Total;56
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Main;56
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Secondary dwellings;74
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Tool;49
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Total;44
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Main;44
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Secondary dwellings;26
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Tool;51
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Total;84
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Main;82
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Secondary dwellings;82
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Tool;96
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total;14,7
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Main;17,1
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Secondary dwellings;2
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Tool;0,4
% Income of an international origin related with activities according to the classification: Operating source abroad;Total;0,8
% Income of an international origin related with activities according to the classification: Operating source abroad;Main;0,2
% Income of an international origin related with activities according to the classification: Operating source abroad;Secondary dwellings;15,5
% Income of an international origin related with activities according to the classification: Operating source abroad;Tool;1,6
% Income of an international origin related with activities according to the classification: Other;Total;0,6
% Income of an international origin related with activities according to the classification: Other;Main;0,5
% Income of an international origin related with activities according to the classification: Other;Secondary dwellings;0,2
% Income of an international origin related with activities according to the classification: Other;Tool;1,5